Biodelivery sciences to exhibit three scientific posters comparing belbuca® to oxycodone at the painweek 2021 conference

Raleigh, n.c., sept. 07, 2021 (globe newswire) -- biodelivery sciences international, inc. (nasdaq: bdsi), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, will showcase three scientific posters regarding belbuca® (buprenorphine buccal film), ciii at the painweek 2021 conference taking place september 7 – 11, 2021 at the cosmopolitan of las vegas.
BDSI Ratings Summary
BDSI Quant Ranking